A detailed history of Qube Research & Technologies LTD transactions in Opti Nose, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 148,551 shares of OPTN stock, worth $114,384. This represents 0.0% of its overall portfolio holdings.

Number of Shares
148,551
Holding current value
$114,384
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$0.82 - $1.44 $121,811 - $213,913
148,551 New
148,551 $154,000
Q1 2023

May 15, 2023

SELL
$1.63 - $2.02 $7,436 - $9,215
-4,562 Reduced 8.85%
46,977 $90,000
Q4 2022

Feb 14, 2023

SELL
$1.68 - $3.7 $20,482 - $45,110
-12,192 Reduced 19.13%
51,539 $95,000
Q3 2022

Nov 14, 2022

BUY
$3.43 - $4.01 $49,985 - $58,437
14,573 Added 29.65%
63,731 $233,000
Q2 2022

Aug 15, 2022

BUY
$1.76 - $3.82 $86,518 - $187,783
49,158 New
49,158 $180,000

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $64.1M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.